← Return to ANA Titer 1:1280 pattern homogeneous and speckled o/w negative work-up
DiscussionANA Titer 1:1280 pattern homogeneous and speckled o/w negative work-up
Autoimmune Diseases | Last Active: 2 days ago | Replies (42)Comment receiving replies
Replies to "@slkanowitz - Hello. Thank you for this information. All the tests you mentioned above except the..."
https://avisetest.com/patient/ctd/
Tests for 23 biomarkers and looks like it tests for 8 autoimmune disorders. From the site:
Patented CB‑CAPs biomarkers
AVISE Lupus, a component of AVISE CTD, is the only validated test that uses patented biomarkers called CB-CAPs that have been proven to outperform standard diagnosis laboratory testing in the detection of SLE.
CB-CAPs identifies significantly more lupus patients that would otherwise appear negative with conventional markers. CB-CAPs are an innovative way to measure abnormality in your immune system that is unique to lupus.
Using CB-CAPs and other lupus-associated markers, AVISE CTD employs an advanced two-tier algorithm and proprietary Index Value to help turn isolated data points into actionable information. The index result is plotted on a spectrum associated with the likelihood of the presence of lupus.